Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
Prakash
Kumar M
KM
Kek
Peng-Chin
PC
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D013956:Antithyroid Agents / Q000627:therapeutic use; D001545:Benserazide / Q000627:therapeutic use; D002231:Carbimazole / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006111:Graves Disease / Q000150:complications; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications*; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D013974:Thyroxine / Q000097:blood
D000978:Antiparkinson Agents; D013956:Antithyroid Agents; D004338:Drug Combinations; C005177:benserazide, levodopa drug combination; D007980:Levodopa; D001545:Benserazide; D002231:Carbimazole; D013974:Thyroxine